Cubist Systematic Strategies, LLC - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q2 2023$117,211
+334.1%
23,210
+45.3%
0.00%
Q3 2022$27,000
-30.8%
15,973
+1.1%
0.00%
Q2 2022$39,000
+11.4%
15,804
+25.8%
0.00%
Q1 2022$35,000
-79.7%
12,560
-61.0%
0.00%
-100.0%
Q4 2021$172,000
-23.6%
32,205
+21.4%
0.00%
-33.3%
Q3 2021$225,000
-80.1%
26,538
-71.5%
0.00%
-76.9%
Q2 2021$1,133,000
+128.0%
92,982
+353.8%
0.01%
+116.7%
Q1 2021$497,000
-18.7%
20,489
+7.5%
0.01%
-25.0%
Q4 2020$611,000
+164.5%
19,063
+248.2%
0.01%
+100.0%
Q2 2020$231,0005,4750.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q2 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders